Meta-analysis of functional network alterations in Alzheimer's disease: Toward a network biomarker

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 5, 2013, Pages 753-765

  Jacobs, Heidi I L ^a   Radua, Joaquim ^b,c   Lückmann, Helen C ^d   Sack, Alexander T ^d  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Alzheimer's disease; Biomarker; Compensation; Connectivity; Default mode network; Meta analysis

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; BRAIN DEPTH STIMULATION; BRAIN DYSFUNCTION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; MENTAL TASK; META ANALYSIS; NERVE CELL NETWORK; PARIETAL CORTEX; PRIORITY JOURNAL; QUANTITATIVE STUDY; REVIEW; SYMPTOM; SYSTEMATIC REVIEW;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, NEUROLOGICAL; NERVE NET;

EID: 84876319362     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2013.03.009     Document Type: Review

References (119)

1. Aggleton J.P. Understanding retrosplenial amnesia: insights from animal studies. Neuropsychologia 2010, 48:2328-2338.
2. Baars L.M.A.E., Van Boxtel M.P.J., Visser P.J., Verhey F.R., Jolles J. Is mild cognitive impairment a stable diagnostic entity?. Alzheimer Dement. 2008, 4:T131.
3. Bai F., Zhang Z., Watson D.R., Yu H., Shi Y., Yuan Y., Qian Y., Jia J. Abnormal integrity of association fiber tracts in amnestic mild cognitive impairment. J. Neurol. Sci. 2009, 278:102-106.
4. Barkhof F., Polvikoski T.M., van Straaten E.C., Kalaria R.N., Sulkava R., Aronen H.J., Niinisto L., Rastas S., Oinas M., Scheltens P., Erkinjuntti T. The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology 2007, 69:1521-1527.
5. Bartlett J.W., Frost C., Mattsson N., Skillback T., Blennow K., Zetterberg H., Schott J.M. Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges. Biomark. Med. 2012, 6:391-400.
6. Beason-Held L.L. Dementia and the default mode. Curr. Alzheimer Res. 2011, 8:361-365.
7. Beason-Held L.L., Kraut M.A., Resnick S.M. Stability of default-mode network activity in the aging brain. Brain Imag. Behav. 2009, 3:123-131.
8. Belleville S., Sylvain-Roy S., de Boysson C., Menard M.C. Characterizing the memory changes in persons with mild cognitive impairment. Prog. Brain Res. 2008, 169:365-375.
9. Bora E., Fornito A., Radua J., Walterfang M., Seal M., Wood S.J., Yucel M., Velakoulis D., Pantelis C. Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis. Schizophrenia Res. 2011, 127:46-57.
10. Bosch B., Bartres-Faz D., Rami L., Arenaza-Urquijo E.M., Fernandez-Espejo D., Junque C., Sole-Padulles C., Sanchez-Valle R., Bargallo N., Falcon C., Molinuevo J.L. Cognitive reserve modulates task-induced activations and deactivations in healthy elders, amnestic mild cognitive impairment and mild Alzheimer's disease. Cortex: J. Devoted Study Nerv. Syst. Behav. 2010, 46:451-461.
11. Bozoki A.C., Korolev I.O., Davis N.C., Hoisington L.A., Berger K.L. Disruption of limbic white matter pathways in mild cognitive impairment and Alzheimer's disease: A DTI/FDG-PET Study. Hum. Brain Map. 2011, 33:1792-1802.
12. Bozzali M., Parker G.J., Serra L., Embleton K., Gili T., Perri R., Caltagirone C., Cercignani M. Anatomical connectivity mapping: a new tool to assess brain disconnection in Alzheimer's disease. Neuroimage 2011, 54:2045-2051.
13. Braak H., Braak E. Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes. J. Neuropathol. Exp. Neurol. 1990, 49:215-224.
14. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
15. Braak H., Braak E. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol. 1996, 92:197-201.
16. Buckner R.L., Andrews-Hanna J.R., Schacter D.L. The brain's default network: anatomy, function, and relevance to disease. Ann. N. Y. Acad. Sci. 2008, 1124:1-38.
17. Buckner R.L., Sepulcre J., Talukdar T., Krienen F.M., Liu H., Hedden T., Andrews-Hanna J.R., Sperling R.A., Johnson K.A. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J. Neurosci.: Off. J. Soc. Neurosci. 2009, 29:1860-1873.
18. Buckner R.L., Wheeler M.E. The cognitive neuroscience of remembering. Nat. Rev. Neurosci. 2001, 2:624-634.
19. Cavanna A.E., Trimble M.R. The precuneus: a review of its functional anatomy and behavioural correlates. Brain 2006, 129:564-583.
20. Celone K.A., Calhoun V.D., Dickerson B.C., Atri A., Chua E.F., Miller S.L., DePeau K., Rentz D.M., Selkoe D.J., Blacker D., Albert M.S., Sperling R.A. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J. Neurosci. 2006, 26:10222-10231.
21. Chen G., Ward B.D., Xie C., Li W., Wu Z., Jones J.L., Franczak M., Antuono P., Li S.J. Classification of Alzheimer disease, mild cognitive impairment, and normal cognitive status with large-scale network analysis based on resting-state functional MR imaging. Radiology 2011, 259:213-221.
22. Clement F., Belleville S. Compensation and disease severity on the memory-related activations in mild cognitive impairment. Biol. Psychiatry 2010, 68:894-902.
23. Consensus Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group. Neurobiol. Aging 1998, 19:109-116.
24. Cummings J.L. Alzheimer's disease. N. Engl. J. Med. 2004, 351:56-67.
25. D'Esposito M., Deouell L.Y., Gazzaley A. Alterations in the BOLD fMRI signal with ageing and disease: a challenge for neuroimaging. Nat. Rev. Neurosci. 2003, 4:863-872.
26. D'Esposito M., Zarahn E., Aguirre G.K., Rypma B. The effect of normal aging on the coupling of neural activity to the bold hemodynamic response. Neuroimage 1999, 10:6-14.
27. Damoiseaux J.S., Seeley W.W., Zhou J., Shirer W.R., Coppola G., Karydas A., Rosen H.J., Miller B.L., Kramer J.H., Greicius M.D. Gender modulates the APOE epsilon4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels. J. Neurosci.: Off. J. Soc. Neurosci. 2012, 32:8254-8262.
28. de Jong L.W., van der Hiele K., Veer I.M., Houwing J.J., Westendorp R.G., Bollen E.L., de Bruin P.W., Middelkoop H.A., van Buchem M.A., van der Grond J. Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study. Brain: J. Neurol. 2008, 131:3277-3285.
29. de Leon M.J., Mosconi L., Blennow K., DeSanti S., Zinkowski R., Mehta P.D., Pratico D., Tsui W., Saint Louis L.A., Sobanska L., Brys M., Li Y., Rich K., Rinne J., Rusinek H. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Ann. N. Y. Acad. Sci. 2007, 1097:114-145.
30. DeKosky S.T., Marek K. Looking backward to move forward: early detection of neurodegenerative disorders. Science 2003, 302:830-834.
31. Delbeuck X., Van der Linden M., Collette F. Alzheimer's disease as a disconnection syndrome?. Neuropsychol. Rev. 2003, 13:79-92.
32. Dickerson B.C., Sperling R.A. Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies. Neuropsychologia 2008, 46:1624-1635.
33. Dubois B., Feldman H.H., Jacova C., Cummings J.L., Dekosky S.T., Barberger-Gateau P., Delacourte A., Frisoni G., Fox N.C., Galasko D., Gauthier S., Hampel H., Jicha G.A., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Sarazin M., de Souza L.C., Stern Y., Visser P.J., Scheltens P. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 2010, 9:1118-1127.
34. Elias-Sonnenschein L.S., Bertram L., Visser P.J. Relationship between genetic risk factors and markers for Alzheimer's disease pathology. Biomark. Med. 2012, 6:477-495.
35. Elias-Sonnenschein L.S., Viechtbauer W., Ramakers I.H., Verhey F.R., Visser P.J. Predictive value of APOE-epsilon4 allele for progression from MCI to AD-type dementia: a meta-analysis. J. Neurol. Neurosurg. Psychiatry 2011, 82:1149-1156.
36. Ewers M., Sperling R.A., Klunk W.E., Weiner M.W., Hampel H. Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci. 2011, 34:430-442.
37. Fanselow M.S., Dong H.W. Are the dorsal and ventral hippocampus functionally distinct structures?. Neuron 2010, 65:7-19.
38. Fleisher A.S., Sherzai A., Taylor C., Langbaum J.B., Chen K., Buxton R.B. Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups. Neuroimage 2009, 47:1678-1690.
39. Fleisher A.S., Sun S., Taylor C., Ward C.P., Gamst A.C., Petersen R.C., Jack C.R., Aisen P.S., Thal L.J. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology 2008, 70:191-199.
40. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatric Res. 1975, 12:189-198.
41. Fortea J., Llado A., Bosch B., Antonell A., Oliva R., Molinuevo J.L., Sanchez-Valle R. Cerebrospinal fluid biomarkers in Alzheimer's disease families with PSEN1 mutations. Neuro-degener. Dis. 2011, 8:202-207.
42. Fransson P., Marrelec G. The precuneus/posterior cingulate cortex plays a pivotal role in the default mode network: evidence from a partial correlation network analysis. Neuroimage 2008, 42:1178-1184.
43. Gili T., Cercignani M., Serra L., Perri R., Giove F., Maraviglia B., Caltagirone C., Bozzali M. Regional brain atrophy and functional disconnection across Alzheimer's disease evolution. J. Neurol. Neurosurg. Psychiatry 2010, 82:58-66.
44. Greicius M.D., Krasnow B., Reiss A.L., Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:253-258.
45. Greicius M.D., Srivastava G., Reiss A.L., Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:4637-4642.
46. Greicius M.D., Supekar K., Menon V., Dougherty R.F. Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb. Cortex 2009, 19:72-78.
47. Guedj E., Barbeau E.J., Didic M., Felician O., de Laforte C., Ranjeva J.P., Poncet M., Cozzone P.J., Mundler O., Ceccaldi M. Effects of medial temporal lobe degeneration on brain perfusion in amnestic MCI of AD type: deafferentation and functional compensation?. Eur. J. Nuclear Med. Mol. Imag. 2009, 36:1101-1112.
48. Gusnard D.A., Raichle M.E., Raichle M.E. Searching for a baseline: functional imaging and the resting human brain. Nat. Rev. Neurosci. 2001, 2:685-694.
49. Hafkemeijer A., van der Grond J., Rombouts S.A. Imaging the default mode network in aging and dementia. Biochim. Biophys. Acta 2012, 1822:431-441.
50. Hagmann P., Cammoun L., Gigandet X., Meuli R., Honey C.J., Wedeen V.J., Sporns O. Mapping the structural core of human cerebral cortex. PLoS Biol. 2008, 6:e159.
51. Hart H., Radua J., Mataix-Cols D., Rubia K. Meta-analysis of fMRI studies of timing in attention-deficit hyperactivity disorder (ADHD). Neurosci. Biobehav. Rev. 2012, 36:2248-2256.
52. Huettel S.A., Song W.A., McCarthy G. Functional Magnetic Resonance Imaging 2004, Sinauer Associates, Inc., Sunderland, MA, USA.
53. Insausti R., Amaral D.G. Entorhinal cortex of the monkey: IV. Topographical and laminar organization of cortical afferents. J. Comp. Neurol. 2008, 509:608-641.
54. Insausti R., Amaral D.G., Cowan W.M. The entorhinal cortex of the monkey: II. Cortical afferents. J. Comp. Neurol. 1987, 264:356-395.
55. Ishii K., Sasaki H., Kono A.K., Miyamoto N., Fukuda T., Mori E. Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies. Eur. J. Nuclear Med. Mol. Imag. 2005, 32:959-963.
56. Jack C.R., Albert M.S., Knopman D.S., McKhann G.M., Sperling R.A., Carrillo M.C., Thies B., Phelps C.H. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:257-262.
57. Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010, 9:119-128.
58. Jacobs H.I.L., Gronenschild E.H.B.M., Evers E.A.T., Ramakers I.H.G.B., Hofman P.A.M., Backes W.H., Jolles J., Verhey F.R.J., Van Boxtel M.P.J. Visuospatial processing in early Alzheimer's disease: a multimodal neuroimaging study. Cortex 2012, 10.1016/j.cortex.2012.1001.1005.
59. Jacobs H.I.L., Van Boxtel M.P., van der Elst W., Burgmans S., Smeets F., Gronenschild E.H., Verhey F.R., Uylings H.B., Jolles J. Increasing the diagnostic accuracy of medial temporal lobe atrophy in Alzheimer's disease. J. Alzheimer's Dis. 2011, 25:477-490.
60. Jacobs H.I.L., Van Boxtel M.P.J., Gronenschild E.H.B.M., Uylings H.B.M., Jolles J., Verhey F.R.J. Decreased grey matter diffusivity: a potential early Alzheimer's disease biomarker?. Alzheimer Dement. 2012, 10.1016/j.jalz.2011.1011.1004.
61. Jacobs H.I.L., Van Boxtel M.P.J., Heinecke A., Gronenschild E.H.B.M., Backes W.H., Jolles J., Verhey F.R.J. Functional integration of parietal lobe activity in early Alzheimer's disease. Neurology 2012, 78:352-360.
62. Jacobs H.I.L., Van Boxtel M.P.J., Jolles J., Verhey F.R.J., Uylings H.B.M. Parietal cortex matters in Alzheimer's disease: an overview of structural, functional and metabolic findings. Neurosci. Biobehav. Rev. 2012, 36:297-309.
63. Jhoo J.H., Lee D.Y., Choo I.H., Seo E.H., Oh J.S., Lee J.S., Lee D.S., Kim S.G., Youn J.C., Kim K.W., Woo J.I. Discrimination of normal aging, MCI and AD with multimodal imaging measures on the medial temporal lobe. Psychiatry Res. 2010, 183:237-243.
64. Kannurpatti S.S., Biswal B.B. Detection and scaling of task-induced fMRI-BOLD response using resting state fluctuations. Neuroimage 2008, 40:1567-1574.
65. Kannurpatti S.S., Motes M.A., Rypma B., Biswal B.B. Increasing measurement accuracy of age-related BOLD signal change: minimizing vascular contributions by resting-state-fluctuation-of-amplitude scaling. Hum. Brain Map. 2011, 32:1125-1140.
66. Kelly A.M., Uddin L.Q., Biswal B.B., Castellanos F.X., Milham M.P. Competition between functional brain networks mediates behavioral variability. Neuroimage 2008, 39:527-537.
67. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., Ausen B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni G., Mathis C.A., Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 2004, 55:306-319.
68. Kobayashi Y., Amaral D.G. Macaque monkey retrosplenial cortex: II. Cortical afferents. J. Comp. Neurol. 2003, 466:48-79.
69. Kobayashi Y., Amaral D.G. Macaque monkey retrosplenial cortex: III. Cortical efferents. J. Comp. Neurol. 2007, 502:810-833.
70. Koch W., Teipel S., Mueller S., Benninghoff J., Wagner M., Bokde A.L., Hampel H., Coates U., Reiser M., Meindl T. Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease. Neurobiol. Aging 2010, 33:466-478.
71. Leech R., Kamourieh S., Beckmann C.F., Sharp D.J. Fractionating the default mode network: distinct contributions of the ventral and dorsal posterior cingulate cortex to cognitive control. J. Neurosci.: Off. J. Soc. Neurosci. 2011, 31:3217-3224.
72. Li S.J., Li Z., Wu G., Zhang M.J., Franczak M., Antuono P.G. Alzheimer Disease: evaluation of a functional MR imaging index as a marker. Radiology 2002, 225:253-259.
73. Lindeboom J., Weinstein H. Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment. Eur. J. Pharmacol. 2004, 490:83-86.
74. Lustig C., Snyder A.Z., Bhakta M., O'Brien K.C., McAvoy M., Raichle M.E., Morris J.C., Buckner R.L. Functional deactivations: change with age and dementia of the Alzheimer type. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:14504-14509.
75. Matsuda H., Kitayama N., Ohnishi T., Asada T., Nakano S., Sakamoto S., Imabayashi E., Katoh A. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J. Nuclear Med. 2002, 43:304-311.
76. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
77. Medina D., DeToledo-Morrell L., Urresta F., Gabrieli J.D., Moseley M., Fleischman D., Bennett D.A., Leurgans S., Turner D.A., Stebbins G.T. White matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study. Neurobiol. Aging 2006, 27:663-672.
78. Mevel K., Chetelat G., Eustache F., Desgranges B. The default mode network in healthy aging and Alzheimer's disease. Int. J. Alzheimer's Dis. 2011, 10.4061/2011/535816.
79. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535.
80. O'Sullivan M., Jones D.K., Summers P.E., Morris R.G., Williams S.C., Markus H.S. Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline. Neurology 2001, 57:632-638.
81. Petersen R.C., Negash S. Mild cognitive impairment: an overview. CNS Spectrums 2008, 13:45-53.
82. Pihlajamaki M., Sperling R.A. Functional MRI assessment of task-induced deactivation of the default mode network in Alzheimer's disease and at-risk older individuals. Behav. Neurol. 2009, 21:77-91.
83. Prvulovic D., Bokde A.L., Faltraco F., Hampel H. Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease. Prog. Neurobiol. 2011, 95:557-569.
84. Prvulovic D., Van de Ven V., Sack A.T., Maurer K., Linden D.E. Functional activation imaging in aging and dementia. Psychiatry Res. 2005, 140:97-113.
85. Radua J., Borgwardt S., Crescini A., Mataix-Cols D., Meyer-Lindenberg A., McGuire P.K., Fusar-Poli P. Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication. Neurosci. Biobehav. Rev. 2012, 36:2325-2333.
86. Radua J., Borgwardt S., Crescini A., Mataix-Cols D., Meyer-Lindenberg A., McGuire P.K., Fusar-Poli P. Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication. Neurosci. Biobehav. Rev. 2012, 36:2325-2333.
87. Radua J., Mataix-Cols D. Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder. Br. J. Psychiatry: J. Mental Sci. 2009, 195:393-402.
88. Radua J., Mataix-Cols D. Meta-analytic methods for neuroimaging data explained. Biol. Mood. Anxiety Disord. 2012, 2:6.
89. Radua J., Mataix-Cols D., Phillips M.L., El-Hage W., Kronhaus D.M., Cardoner N., Surguladze S. A new meta-analytic method for neuroimaging studies that combines reported peak coordinates and statistical parametric maps. Eur. Psychiatry 2011, 27:605-611.
90. Radua J., Romeo M., Mataix-Cols D., Fusar-Poli P. A general approach for combining voxel-based meta-analyses conducted in different neuroimaging modalities. Curr. Med. Chem. 2013, 20:462-466.
91. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. A default mode of brain function. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:676-682.
92. Rilling J.K., Barks S.K., Parr L.A., Preuss T.M., Faber T.L., Pagnoni G., Bremner J.D., Votaw J.R. A comparison of resting-state brain activity in humans and chimpanzees. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:17146-17151.
93. Rombouts S.A., Goekoop R., Stam C.J., Barkhof F., Scheltens P. Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease. Neuroimage 2005, 26:1078-1085.
94. Rose S.E., Janke A.L., Chalk J.B. Gray and white matter changes in Alzheimer's disease: a diffusion tensor imaging study. J. Magnet. Reson. Imag. 2008, 27:20-26.
95. Sack A.T. Parietal cortex and spatial cognition. Behav. Brain Res. 2009, 202:153-161.
96. Salat D.H., Tuch D.S., van der Kouwe A.J., Greve D.N., Pappu V., Lee S.Y., Hevelone N.D., Zaleta A.K., Growdon J.H., Corkin S., Fischl B., Rosas H.D. White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol. Aging 2010, 31:244-256.
97. Scheltens P., Leys D., Barkhof F., Huglo D., Weinstein H.C., Vermersch P., Kuiper M., Steinling M., Wolters E.C., Valk J. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J. Neurol. Neurosurg. Psychiatry 1992, 55:967-972.
98. Sheline Y.I., Morris J.C., Snyder A.Z., Price J.L., Yan Z., D'Angelo G., Liu C., Dixit S., Benzinger T., Fagan A., Goate A., Mintun M.A. APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Abeta42. J. Neurosci.: Off. J. Soc. Neurosci. 2010, 30:17035-17040.
99. Sherman S.M. Thalamic relay functions. Progr. Brain Res. 2001, 134:51-69.
100. Smyser C.D., Inder T.E., Shimony J.S., Hill J.E., Degnan A.J., Snyder A.Z., Neil J.J. Longitudinal analysis of neural network development in preterm infants. Cereb. Cortex 2010, 20:2852-2862.
101. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997, 277:813-817.
102. Sorg C., Riedl V., Muhlau M., Calhoun V.D., Eichele T., Laer L., Drzezga A., Forstl H., Kurz A., Zimmer C., Wohlschlager A.M. Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:18760-18765.
103. Sperling R.A., Aisen P.S., Beckett L.A., Bennett D.A., Craft S., Fagan A.M., Iwatsubo T., Jack C.R., Kaye J., Montine T.J., Park D.C., Reiman E.M., Rowe C.C., Siemers E., Stern Y., Yaffe K., Carrillo M.C., Thies B., Morrison-Bogorad M., Wagster M.V., Phelps C.H. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer Dement. 2011, 7:280-292.
104. Sperling R.A., Bates J.F., Chua E.F., Cocchiarella A.J., Rentz D.M., Rosen B.R., Schacter D.L., Albert M.S. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2003, 74:44-50.
105. Stern Y. Cognitive reserve and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2006, 20:S69-S74.
106. Teipel S.J., Bokde A.L., Meindl T., Amaro E., Soldner J., Reiser M.F., Herpertz S.C., Moller H.J., Hampel H. White matter microstructure underlying default mode network connectivity in the human brain. Neuroimage 2010, 49:2021-2032.
107. Teipel S.J., Meindl T., Wagner M., Stieltjes B., Reuter S., Hauenstein K.H., Filippi M., Ernemann U., Reiser M.F., Hampel H. Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study. J. Alzheimer Dis. 2010, 22:507-522.
108. Thal D.R., Rub U., Orantes M., Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002, 58:1791-1800.
109. Uddin L.Q., Kelly A.M., Biswal B.B., Xavier Castellanos F., Milham M.P. Functional connectivity of default mode network components: correlation, anticorrelation, and causality. Hum. Brain Map. 2009, 30:625-637.
110. van den Heuvel M., Mandl R., Luigjes J., Hulshoff Pol H. Microstructural organization of the cingulum tract and the level of default mode functional connectivity. J. Neurosci.: Off. J. Soc. Neurosci. 2008, 28:10844-10851.
111. Vann S.D., Aggleton J.P., Maguire E.A. What does the retrosplenial cortex do?. Nat. Rev. Neurosci. 2009, 10:792-802.
112. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 2010, 36:1-48.
113. Visser P.J., Verhey F.R., Hofman P.A., Scheltens P., Jolles J. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J. Neurol. Neurosurg. Psychiatry 2002, 72:491-497.
114. Vogt B.A., Nimchinsky E.A., Vogt L.J., Hof P.R. Human cingulate cortex: surface features, flat maps, and cytoarchitecture. J. Comp. Neurol. 1995, 359:490-506.
115. Vogt B.A., Vogt L., Laureys S. Cytology and functionally correlated circuits of human posterior cingulate areas. Neuroimage 2006, 29:452-466.
116. Wermke M., Sorg C., Wohlschlager A.M., Drzezga A. A new integrative model of cerebral activation, deactivation and default mode function in Alzheimer's disease. Eur. J. Nuclear Med. Mol. Imag. 2008, 35(Suppl 1):S12-S24.
117. Wilson R.S., Leurgans S.E., Boyle P.A., Bennett D.A. Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch. Neurol. 2011, 68:351-356.
118. Wimo A., Winblad B., Aguero-Torres H., von Strauss E. The magnitude of dementia occurrence in the world. Alzheimer Dis. Assoc. Disord. 2003, 17:63-67.
119. Zhang H.Y., Wang S.J., Liu B., Ma Z.L., Yang M., Zhang Z.J., Teng G.J. Resting brain connectivity: changes during the progress of Alzheimer disease. Radiology 2010, 256:598-606.